Marc Remke Selected Research

Telomerase (Telomerase Reverse Transcriptase)

1/2019	DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
12/2014	Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
12/2014	Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.
12/2013	TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Remke Research Topics

Disease

89	Neoplasms (Cancer) 05/2024 - 05/2008
64	Medulloblastoma 11/2023 - 04/2009
16	Brain Neoplasms (Brain Tumor) 10/2023 - 10/2013
14	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 10/2014
9	Glioma (Gliomas) 04/2024 - 05/2008
7	Astrocytoma (Pilocytic Astrocytoma) 10/2023 - 05/2008
7	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2012
6	Ependymoma 01/2022 - 07/2010
6	Primitive Neuroectodermal Tumors (PNET) 01/2017 - 09/2007
3	Starvation 05/2024 - 01/2017
3	Melanoma (Melanoma, Malignant) 01/2023 - 01/2022
3	Neuroblastoma 01/2023 - 01/2017
3	Typical Teratoid Rhabdoid Tumor 01/2023 - 01/2017
3	Hypoxia (Hypoxemia) 01/2020 - 01/2016
2	Leukemia 12/2023 - 01/2018
2	Inflammation (Inflammations) 01/2023 - 01/2020
2	Carcinogenesis 07/2021 - 06/2014
2	Pinealoma (Pineoblastoma) 01/2020 - 09/2012
2	Tics (Tic) 01/2019 - 12/2014
2	Diffuse Intrinsic Pontine Glioma 01/2017 - 12/2014
1	Hodgkin Disease (Hodgkin's Disease) 04/2024
1	Fasciitis (Fascitis) 04/2024
1	Poliomyelitis (Polio) 03/2023
1	Experimental Melanoma 01/2023
1	Disease Progression 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2022

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 11/2023 - 04/2009
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2009
12	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 09/2007
8	Phosphotransferases (Kinase)IBA 05/2024 - 05/2014
8	Messenger RNA (mRNA)IBA 03/2023 - 05/2008
8	MicroRNAs (MicroRNA)IBA 01/2018 - 04/2009
6	Histone Deacetylase InhibitorsIBA 05/2023 - 06/2010
5	Long Noncoding RNAIBA 11/2023 - 01/2019
4	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2023 - 11/2012
4	ChromatinIBA 01/2023 - 12/2015
4	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2012
4	Transcription Factors (Transcription Factor)IBA 12/2022 - 11/2019
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019 - 12/2013
4	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 08/2016
4	ParaffinIBA 01/2016 - 04/2012
4	Formaldehyde (Formol)FDA Link 01/2016 - 04/2012
3	Carrier Proteins (Binding Protein)IBA 05/2024 - 10/2014
3	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 06/2022
3	CytokinesIBA 04/2024 - 01/2020
3	Histones (Histone)IBA 01/2023 - 03/2013
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 06/2010
3	Small Interfering RNA (siRNA)IBA 10/2010 - 05/2008
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2024 - 01/2020
2	Conditioned Culture MediaIBA 04/2024 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 12/2022
2	InterferonsIBA 10/2023 - 01/2020
2	entinostat (MS 275)IBA 05/2023 - 01/2021
2	Circular RNAIBA 01/2023 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 01/2019
2	dactolisibIBA 01/2023 - 12/2014
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2022 - 02/2022
2	Sirolimus (Rapamycin)FDA Link 02/2022 - 04/2012
2	ProteomeIBA 01/2020 - 10/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 07/2014
2	AntibodiesIBA 01/2019 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 01/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2016 - 08/2015
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 11/2015 - 01/2014
2	Proto-Oncogene Proteins B-rafIBA 11/2011 - 04/2011
1	Eukaryotic Initiation Factor-4EIBA 05/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2023
1	Etoposide (VP 16)FDA LinkGeneric 11/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2023
1	Mitogen-Activated Protein KinasesIBA 10/2023
1	Adenosine Triphosphate (ATP)IBA 05/2023
1	poliovirus receptorIBA 03/2023
1	5-nonyloxytryptamineIBA 01/2023
1	Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA 01/2023
1	tacedinaline (CI 994)IBA 01/2023
1	AntigensIBA 01/2023
1	EpitopesIBA 01/2023
1	Doxycycline (Periostat)FDA LinkGeneric 12/2022
1	CateninsIBA 06/2022
1	Oncogene Proteins (Oncogene Protein)IBA 06/2022
1	Staphylococcal Protein A (Protein A)IBA 02/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 02/2022
1	Lactate Dehydrogenase 5IBA 01/2022
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2022
1	GlutaredoxinsIBA 01/2022
1	ProdrugsIBA 01/2022
1	PlasticsIBA 01/2022
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022
1	Folic Acid AntagonistsIBA 01/2022
1	Dyneins (Dynein)IBA 01/2022

Therapy/Procedure

45	Therapeutics 12/2023 - 10/2008
12	Drug Therapy (Chemotherapy) 12/2020 - 08/2012
4	Radiotherapy 01/2021 - 10/2013
3	Immunotherapy 01/2023 - 01/2022
2	Chemoradiotherapy 06/2022 - 01/2016
2	Craniospinal Irradiation 09/2017 - 01/2016
1	Second-Look Surgery 01/2022